Clinical Trial: Clustered tDCS Sessions for Reducing Alcohol Consumption in Non-abstinent Patients With Alcohol Use Disorder

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442786) titled 'Clustered tDCS Sessions for Reducing Alcohol Consumption in Non-abstinent Patients With Alcohol Use Disorder' on Feb. 24.

Brief Summary: The global burden of disease and injury attributable to alcohol is considerable: worldwide, 5.3% of deaths are directly related to alcohol. In France, 41 000 deaths were attributable to alcohol in 2015. Alcohol can cause more than 200 diseases. There is an important social cost attached to alcohol, which is estimated at 120 billion euros in France in 2010.

There is a scientific and clinical rationale for promoting alcohol reduction in alcohol use disorder (AUD). Alcohol harm reduction strategies h...